Problems with ABPI proposals to release data on payments to doctorsBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1301 (Published 05 February 2014) Cite this as: BMJ 2014;348:g1301
- Ben Goldacre, research fellow1
- 1London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
Whitehead of the Association of the British Pharmaceutical Industry (ABPI) says the drug industry will soon declare all payments to doctors.1 2 There are several problems with his new promises.
Firstly, industry has been promising such transparency for years, without delivering. At the same time, the same companies are campaigning against transparency in other areas.
Secondly, industry representatives now say—when directly questioned about completeness—that EU privacy law will permit individual doctors …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial